Iván O. Rosas

23.8k total citations · 6 hit papers
190 papers, 9.5k citations indexed

About

Iván O. Rosas is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Iván O. Rosas has authored 190 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Pulmonary and Respiratory Medicine, 35 papers in Physiology and 34 papers in Molecular Biology. Recurrent topics in Iván O. Rosas's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (110 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (44 papers) and Medical Imaging and Pathology Studies (23 papers). Iván O. Rosas is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (110 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (44 papers) and Medical Imaging and Pathology Studies (23 papers). Iván O. Rosas collaborates with scholars based in United States, China and Canada. Iván O. Rosas's co-authors include Bernadette R. Gochuico, Stefan W. Ryter, Gary M. Hunninghake, Naftali Kaminski, B.J. Moss, George R. Washko, Souheil El‐Chemaly, Tracy J. Doyle, Danielle Morse and Hiroto Hatabu and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Iván O. Rosas

179 papers receiving 9.4k citations

Hit Papers

Single-cell RNA-seq reveals ect... 2010 2026 2015 2020 2020 2014 2010 2021 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iván O. Rosas United States 49 6.3k 2.2k 1.7k 1.1k 1.0k 190 9.5k
Carlyne D. Cool United States 58 8.9k 1.4× 2.5k 1.1× 1.9k 1.2× 1.2k 1.1× 1.2k 1.2× 173 11.8k
Tamiko Takemura Japan 47 3.8k 0.6× 1.4k 0.7× 2.1k 1.3× 997 0.9× 697 0.7× 389 7.9k
Carol Feghali‐Bostwick United States 56 4.1k 0.7× 3.6k 1.6× 877 0.5× 1.3k 1.2× 1.4k 1.4× 176 9.9k
Akihito Yokoyama Japan 40 3.1k 0.5× 1.5k 0.7× 1.6k 1.0× 627 0.6× 1.0k 1.0× 239 6.5k
Annie Pardo Mexico 70 14.0k 2.2× 4.2k 1.9× 2.7k 1.6× 1.5k 1.3× 1.5k 1.5× 193 18.7k
Eunhee S. Yi United States 52 4.9k 0.8× 1.7k 0.8× 1.2k 0.7× 1.5k 1.3× 881 0.9× 216 9.0k
Robin J. McAnulty United Kingdom 52 3.7k 0.6× 1.9k 0.9× 901 0.5× 471 0.4× 765 0.8× 121 7.4k
Roel Goldschmeding Netherlands 65 2.6k 0.4× 5.4k 2.5× 1.4k 0.9× 699 0.6× 1.5k 1.5× 259 12.3k
Élie Fadel France 66 9.3k 1.5× 2.1k 0.9× 722 0.4× 1.1k 0.9× 515 0.5× 355 12.8k
Frédéric Perros France 45 5.3k 0.8× 1.7k 0.8× 1.2k 0.7× 418 0.4× 1.4k 1.4× 127 7.8k

Countries citing papers authored by Iván O. Rosas

Since Specialization
Citations

This map shows the geographic impact of Iván O. Rosas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iván O. Rosas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iván O. Rosas more than expected).

Fields of papers citing papers by Iván O. Rosas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iván O. Rosas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iván O. Rosas. The network helps show where Iván O. Rosas may publish in the future.

Co-authorship network of co-authors of Iván O. Rosas

This figure shows the co-authorship network connecting the top 25 collaborators of Iván O. Rosas. A scholar is included among the top collaborators of Iván O. Rosas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iván O. Rosas. Iván O. Rosas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McKenna, Neil J., Scott A. Ochsner, B.J. Moss, et al.. (2025). Single Cell Transcriptomics in a Treatment Status Segregated Cohort Exposes a STAT3-Regulated Therapeutic Gap in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5273–A5273.
2.
Putman, Rachel K., Jonathan A. Rose, R. San José Estépar, et al.. (2025). Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGene. American Journal of Respiratory and Critical Care Medicine. 211(10). 1794–1801.
3.
Mao, Hua, Bing Sun, Christopher Ward, et al.. (2025). Inhibition of BMPER Mitigates Pulmonary Hypertension by Modulating LRP1-YAP Interaction in Smooth Muscle Cells. Arteriosclerosis Thrombosis and Vascular Biology. 45(11). 2037–2052.
4.
Liu, Yunqing, Ningshan Li, Gang Xu, et al.. (2024). SDePER: a hybrid machine learning and regression method for cell-type deconvolution of spatial barcoding-based transcriptomic data. Genome biology. 25(1). 271–271. 4 indexed citations
5.
Justet, A., Taylor Adams, Nilay Mitash, et al.. (2024). Fibrotic cocktail treated human precision lung slices replicate the cellular diversity of the IPF lung. Revue des Maladies Respiratoires. 41(3). 218–218. 1 indexed citations
6.
Wang, Lan, Cong Xia, Zhongzheng Li, et al.. (2023). TRIOBP modulates β-catenin signaling by regulation of miR-29b in idiopathic pulmonary fibrosis. Cellular and Molecular Life Sciences. 81(1). 13–13. 3 indexed citations
7.
Shivram, Haridha, Jason A. Hackney, Carrie M. Rosenberger, et al.. (2023). Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19. iScience. 26(9). 107597–107597. 3 indexed citations
8.
Xu, Kai, Yanan Hu, Yuexia Yang, et al.. (2023). Tuftelin1 drives experimental pulmonary fibrosis progression by facilitating stress fiber assembly. Respiratory Research. 24(1). 318–318. 6 indexed citations
9.
Lim, Clarice X., Alexandre F. Carisey, Scott A. Ochsner, et al.. (2023). SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8 + T cells. Science Translational Medicine. 15(713). eade2581–eade2581. 3 indexed citations
10.
Esposito, Anthony J., Shikshya Shrestha, Marina Vivero, et al.. (2023). Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion. Jornal Brasileiro de Pneumologia. 49(2). e20220356–e20220356. 4 indexed citations
11.
Nakahara, Yoshio, Naozumi Hashimoto, Koji Sakamoto, et al.. (2021). Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis. European Respiratory Journal. 58(6). 2003397–2003397. 27 indexed citations
12.
Sun, Bo, Ari J. Salinger, Ronak Tilvawala, et al.. (2021). PAD2-mediated citrullination of Fibulin-5 promotes elastogenesis. Matrix Biology. 102. 70–84. 11 indexed citations
13.
Hettiarachchi, Suraj U., Jyoti Roy, Fenghua Zhang, et al.. (2020). Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models. Science Translational Medicine. 12(567). 69 indexed citations
14.
Adams, Taylor, Jonas C. Schupp, Sergio Poli, et al.. (2020). Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Science Advances. 6(28). eaba1983–eaba1983. 704 indexed citations breakdown →
15.
Raredon, Micha Sam Brickman, Taylor Adams, Yasir Suhail, et al.. (2019). Single-cell connectomic analysis of adult mammalian lungs. Science Advances. 5(12). eaaw3851–eaaw3851. 116 indexed citations
16.
Cui, Ye, Wendy K. Steagall, Gustavo Pacheco–Rodriguez, et al.. (2017). Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation. Cancer Research. 77(6). 1492–1502. 15 indexed citations
17.
Travers, Timothy, Lisa A. Harlow, Iván O. Rosas, et al.. (2016). Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes. The Journal of Immunology. 197(5). 1926–1936. 24 indexed citations
18.
Stout-Delgado, Heather W., Soo Jung Cho, Sarah Chu, et al.. (2016). Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation. American Journal of Respiratory Cell and Molecular Biology. 55(2). 252–263. 112 indexed citations
19.
Liu, Fei, David Lagares, Kyoung Moo Choi, et al.. (2014). Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 308(4). L344–L357. 617 indexed citations breakdown →
20.
Wilson, Mark S., Satish K. Madala, Thirumalai R. Ramalingam, et al.. (2010). Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent. The Journal of Experimental Medicine. 207(3). 535–552. 591 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026